Joseph P. Lucia & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Buy
484
+160
+49% +$163K 0.17% 102
2026
Q1
$298K Hold
324
– – 0.11% 133
2025
Q4
$348K Sell
324
-30
-8% -$28.7K 0.13% 125
2025
Q3
$270K Sell
354
-124
-26% -$92.3K 0.1% 136
2025
Q2
$372K Buy
478
+27
+6% +$21K 0.15% 112
2025
Q1
$372K Buy
451
+19
+4% +$15.8K 0.17% 101
2024
Q4
$334K Sell
432
-167
-28% -$138K 0.15% 99
2024
Q3
$531K Buy
599
+268
+81% +$241K 0.24% 78
2024
Q2
$300K Buy
331
+30
+10% +$24K 0.15% 93
2024
Q1
$234K Buy
+301
New +$214K 0.13% 107

Other funds holding LLY

Joseph P. Lucia & Associates's LLY Position: Q2 2026 in Review

Joseph P. Lucia & Associates increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $163K and bringing the position to 484 shares worth $581K. The position accounts for 0.17% of the portfolio, ranked #102.

Joseph P. Lucia & Associates first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Joseph P. Lucia & Associates held 484 shares of Eli Lilly worth $581K as of Q2 2026.
  • Joseph P. Lucia & Associates bought 160 Eli Lilly shares in Q2 2026, an estimated $163K.
  • Eli Lilly made up 0.17% of Joseph P. Lucia & Associates's portfolio in Q2 2026, its #102 holding.
  • Joseph P. Lucia & Associates first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Joseph P. Lucia & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.